Christopher R. Stone

Array ( [id] => 4786189 [patent_doc_number] => 20080139518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Topical compositions for treatment of skin conditions' [patent_app_type] => utility [patent_app_number] => 11/999145 [patent_app_country] => US [patent_app_date] => 2007-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12473 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20080139518.pdf [firstpage_image] =>[orig_patent_app_number] => 11999145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4944511 [patent_doc_number] => 20080081838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-03 [patent_title] => 'Inhibition of TNF-alpha-Initiated Neutrophil Response' [patent_app_type] => utility [patent_app_number] => 11/837964 [patent_app_country] => US [patent_app_date] => 2007-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13876 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20080081838.pdf [firstpage_image] =>[orig_patent_app_number] => 11837964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5404639 [patent_doc_number] => 20090239953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'USE OF AN ANTI-CANCER COMPOUND' [patent_app_type] => utility [patent_app_number] => 12/374279 [patent_app_country] => US [patent_app_date] => 2007-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 7181 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239953.pdf [firstpage_image] =>[orig_patent_app_number] => 12374279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4880409 [patent_doc_number] => 20080153792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'Drug Identification and Treatment Method' [patent_app_type] => utility [patent_app_number] => 11/942689 [patent_app_country] => US [patent_app_date] => 2007-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49024 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20080153792.pdf [firstpage_image] =>[orig_patent_app_number] => 11942689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6257540 [patent_doc_number] => 20100029674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'Methods of Using Phosphoantigen for the Treatment of Cancer' [patent_app_type] => utility [patent_app_number] => 12/438998 [patent_app_country] => US [patent_app_date] => 2007-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 35642 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029674.pdf [firstpage_image] =>[orig_patent_app_number] => 12438998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4846437 [patent_doc_number] => 20080182845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'METHOD OF PREVENTING OR TREATING ORGAN, HEMATOPOIETIC STEM CELL OR BONE MARROW TRANSPLANT REJECTION' [patent_app_type] => utility [patent_app_number] => 11/941196 [patent_app_country] => US [patent_app_date] => 2007-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 28569 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20080182845.pdf [firstpage_image] =>[orig_patent_app_number] => 11941196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4846414 [patent_doc_number] => 20080182822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'Liquid Pharmaceutical Compositions Comprising a Bisphosphonate Compound' [patent_app_type] => utility [patent_app_number] => 11/941393 [patent_app_country] => US [patent_app_date] => 2007-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16851 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20080182822.pdf [firstpage_image] =>[orig_patent_app_number] => 11941393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4927908 [patent_doc_number] => 20080167271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS COMPRISING A BISPHOSPHONATE COMPOUND' [patent_app_type] => utility [patent_app_number] => 11/941417 [patent_app_country] => US [patent_app_date] => 2007-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16823 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20080167271.pdf [firstpage_image] =>[orig_patent_app_number] => 11941417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7545489 [patent_doc_number] => 08053461 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-08 [patent_title] => 'Oxindole derivative' [patent_app_type] => utility [patent_app_number] => 12/513332 [patent_app_country] => US [patent_app_date] => 2007-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 16 [patent_no_of_words] => 11337 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/053/08053461.pdf [firstpage_image] =>[orig_patent_app_number] => 12513332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4698920 [patent_doc_number] => 20080221104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'SOLUBLE EPOXIDE HYDROLASE INHIBITORS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS' [patent_app_type] => utility [patent_app_number] => 11/934642 [patent_app_country] => US [patent_app_date] => 2007-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16105 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20080221104.pdf [firstpage_image] =>[orig_patent_app_number] => 11934642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9099631 [patent_doc_number] => 08563509 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-22 [patent_title] => 'Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates' [patent_app_type] => utility [patent_app_number] => 11/927235 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 41 [patent_no_of_words] => 14572 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11927235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7966513 [patent_doc_number] => 07939550 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-10 [patent_title] => 'Aminopyrazole derivatives, process for the preparation thereof, and composition for preventing or treating ischemic diseases containing the same' [patent_app_type] => utility [patent_app_number] => 12/447394 [patent_app_country] => US [patent_app_date] => 2007-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15452 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/939/07939550.pdf [firstpage_image] =>[orig_patent_app_number] => 12447394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6442736 [patent_doc_number] => 20100104673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'Methods and Compositions for Treatment of Skin Conditions' [patent_app_type] => utility [patent_app_number] => 12/446946 [patent_app_country] => US [patent_app_date] => 2007-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4714 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20100104673.pdf [firstpage_image] =>[orig_patent_app_number] => 12446946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4697791 [patent_doc_number] => 20080219975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'VEGFR3 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 11/875288 [patent_app_country] => US [patent_app_date] => 2007-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10230 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20080219975.pdf [firstpage_image] =>[orig_patent_app_number] => 11875288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5509166 [patent_doc_number] => 20090082373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'Uses of 2-[piperidinyl]methyl-2, 3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one for providing an analgesic effect, anti-allergic effect and histamine H1 receptor antagonism effect' [patent_app_type] => utility [patent_app_number] => 11/907853 [patent_app_country] => US [patent_app_date] => 2007-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1935 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082373.pdf [firstpage_image] =>[orig_patent_app_number] => 11907853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6296448 [patent_doc_number] => 20100240653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'BIPHENYL SULFONYL AND PHENYL-HETEROARYL SULFONYL MODULATORS OF THE HISTAMINE H3-RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO' [patent_app_type] => utility [patent_app_number] => 12/445795 [patent_app_country] => US [patent_app_date] => 2007-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 42443 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20100240653.pdf [firstpage_image] =>[orig_patent_app_number] => 12445795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10498530 [patent_doc_number] => 09226919 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-05 [patent_title] => 'Methods for dosing an orally active 1,2,4-oxadiazole' [patent_app_type] => utility [patent_app_number] => 11/974068 [patent_app_country] => US [patent_app_date] => 2007-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22282 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11974068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4827050 [patent_doc_number] => 20080125454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Methods and Compositions for Treatment of Scleritis and Related Disorders' [patent_app_type] => utility [patent_app_number] => 11/868052 [patent_app_country] => US [patent_app_date] => 2007-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 29619 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20080125454.pdf [firstpage_image] =>[orig_patent_app_number] => 11868052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6355818 [patent_doc_number] => 20100022512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'COMPOSITIONS OF CHK1 INHIBITORS AND CYCLODEXTRIN' [patent_app_type] => utility [patent_app_number] => 12/442529 [patent_app_country] => US [patent_app_date] => 2007-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28348 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022512.pdf [firstpage_image] =>[orig_patent_app_number] => 12442529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4710524 [patent_doc_number] => 20080299050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'TOPICAL THERAPIES FOR ORAL MUCOSITIS AND OTHER CONDITIONS' [patent_app_type] => utility [patent_app_number] => 11/865476 [patent_app_country] => US [patent_app_date] => 2007-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12166 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20080299050.pdf [firstpage_image] =>[orig_patent_app_number] => 11865476 [rel_patent_id] =>[rel_patent_doc_number] =>)